Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) Biotech Break Out


New York, NY -- (ReleaseWire) -- 01/28/2013 -- Growing Stock Report iniates a Biotech Break Out Alert List and Investor Poll for the following stocks: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) and Dendreon Corp. (NASDAQ:DNDN)

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) as of this writing is up (+41.49%) on over 10,731,287 Shares Traded. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) this morning announced successful top-line results from the long-term Phase 3 study of Zerenex™ (ferric citrate), the Company's ferric iron-based phosphate binder drug candidate, for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis. This long-term study was the final component of the Company's Phase 3 registration program, which was conducted pursuant to a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

The Stock is acting favorable which has prompted Growing Stock Report to Add Keryx Biopharmaceuticals Inc. (Nasdaq:KERX) to their Biotech Break Out Alert List.

Click Here to See What Other Investors Are Saying.

Dendreon Corp. (NASDAQ:DNDN) as of this writing is currently up (+2.40%) on 928,265 Shares Traded. Dendreon Corp. (NASDAQ:DNDN) a company that engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients is up (+73.44%) intra-day from it's 52-Week Low of $3.69 which has prompted Growing Stock Report to Add Dendreon Corp. (NASDAQ:DNDN) to their Biotech Break Out Alert List.

Click Here to See what Investors are Saying About Dendreon Corp. (NASDAQ:DNDN) monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:

Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Contact Info:
Growing Stock Report